(NASDAQ: GHSI) Enters into Definitive Agreement to Sell its Viactiv Brand and Business to Doctor’s Best
DENVER, Colo., Jan. 31, 2023 (247marketnews.com)- Guardion Health Sciences, Inc. (NASDAQ:GHSI) reported, after yesterday’s market close, that it signed an equity purchase agreement to sell its Activ Nutritional, LLC subsidiary and its Viactiv brand and business, to Doctor’s Best, a wholly-owned subsidiary of Kingdomway USA, for $17.2 million, in cash, payable in full at closing. The transaction has been approved by the respective Boards of Directors of Guardion and of Doctor’s Best, and remains subject to normal and customary closing conditions, including approval of the transaction by the Company’s stockholders at a forthcoming Special Meeting of Stockholders, and is expected to close during the quarter ending June 30, 2024.
Guardion Health Sciences is trading at $8.92, up $3.77 (+67.04%), on 2.3M premarket shares traded.
Its 52-week range is $4.655 to $8.25. It should hit a new 52-week high in today’s regular trading session.
Guardion Health Sciences, Inc. is a clinical nutrition company that offers a portfolio of science-based, clinically supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients.
Website www.viactiv.com
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.
The stocks and strategies discussed are simply ideas only and are in no way financial advice or recommendations. The author may or may not at any time be holding securities discussed. The author may or may not enter trades in the stocks mentioned. Some positions in mentioned stocks may already be held or are being adjusted or are simply examples, ideas or discussion topics. You are always trading at your own risk.
Few succeed in the stock market. Don’t trade if you’re not able to devote the necessary time. Earmark your surplus funds that you’re prepared to lose. Assess your risk appetite and set your stops accordingly, and honor your stop losses. Always employ loss limiting strategies. Be prepared to be blindsided by hidden risks, a bad company financing or other move can turn gains into losses.
Learn technical analysis, charting, patterns, and setups. Buying at the bottom and selling at the top is a myth. The middle half of a move is the sweet spot and learn how to exit a winning position, because trying to time the exact top can turn into big losses. Trade small and take advantage of small price move strategies, like scalping.
Remove emotional and psychological biases, and consider that you’re competing against professionals who’re deploying a number of powerful stock market tools. Successful traders make more on their winners than they lose on their losers. Learn how to interpret the ECN/Level 2 data.
Please go to 247marketnews.com or https://247marketnews.com/terms-disclaimer/ for further information.